Brief: Arocell AB Says Dialogue Has Been Held With FDA Regarding 510(K) Submission That Co Submitted On May 26
Sept 22 (Reuters) - AroCell AB (publ) AROC.ST :
* AROCELL AB - DIALOGUE HAS BEEN HELD WITH U.S. FDA
REGARDING
510(K) SUBMISSION THAT CO SUBMITTED ON MAY 26, 2020
* AROCELL AB - IN DIALOGUE WITH FDA, AROCELL RECEIVED
QUESTIONS
REGARDING 510(K) SUBMISSION
* AROCELL AB - INTENDS TO PROCESS QUESTIONS REGARDING
510(K)
SUBMISSION AND UPDATE APPLICATION WITHIN A FEW WEEKS
Source text for Eikon: ID:nNDL8Dq0yV
Further company coverage: AROC.ST
((Reuters.Briefs@thomsonreuters.com;))